TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease - Danese, S; Sans, M; Scaldaferri, F (J Immunol, 2006)
et al.